De-Escalated Neoadjuvant Weekly Nab-Paclitaxel with Trastuzumab and Pertuzumab in HER2-Positive Early Breast Cancer (HELEN-006): A Randomized, Phase 3 Trial
Publication
, Journal Article
Chen, X-C; Jiao, D-C; Qiao, J-H; Wang, C-Z; Sun, X-F; Lu, Z-D; Li, L-F; Zhang, C-J; Yan, M; Wei, Y; Chen, B; Feng, Y-Q; Deng, M; Ma, M ...
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Chen, X.-C., Jiao, D.-C., Qiao, J.-H., Wang, C.-Z., Sun, X.-F., Lu, Z.-D., … Liu, Z. (n.d.). De-Escalated Neoadjuvant Weekly Nab-Paclitaxel with Trastuzumab and Pertuzumab in HER2-Positive Early Breast Cancer (HELEN-006): A Randomized, Phase 3 Trial.
Chen, Xiu-Chun, De-Chuang Jiao, Jiang-Hua Qiao, Cheng-Zheng Wang, Xian-Fu Sun, Zhen-Duo Lu, Lian-Fang Li, et al. “De-Escalated Neoadjuvant Weekly Nab-Paclitaxel with Trastuzumab and Pertuzumab in HER2-Positive Early Breast Cancer (HELEN-006): A Randomized, Phase 3 Trial,” n.d.
Chen X-C, Jiao D-C, Qiao J-H, Wang C-Z, Sun X-F, Lu Z-D, et al. De-Escalated Neoadjuvant Weekly Nab-Paclitaxel with Trastuzumab and Pertuzumab in HER2-Positive Early Breast Cancer (HELEN-006): A Randomized, Phase 3 Trial.
Chen X-C, Jiao D-C, Qiao J-H, Wang C-Z, Sun X-F, Lu Z-D, Li L-F, Zhang C-J, Yan M, Wei Y, Chen B, Feng Y-Q, Deng M, Ma M, Plichta JK, He Y, Liu Z. De-Escalated Neoadjuvant Weekly Nab-Paclitaxel with Trastuzumab and Pertuzumab in HER2-Positive Early Breast Cancer (HELEN-006): A Randomized, Phase 3 Trial.